BAYLY ADAMS: Open Payments
NPI 1295443653 · MOUNT VERNON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,141 in 64 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $555 · 2025 $1,141
Food & beverage: $1,141
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $312 |
| AstraZeneca Pharmaceuticals LP | 11 | $227 |
| Lilly USA, LLC | 10 | $176 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $79 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| ABBVIE INC. | 3 | $48 |
| Viatris Specialty LLC | 2 | $32 |
| Dexcom, Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $20 |
Products named: BREZTRI, MOUNJARO, ENTYVIO, FARXIGA, Rybelsus, Ozempic, JARDIANCE, TRELEGY ELLIPTA.
Industry payments across IL — which companies pay providers there.
